Company

Nagisa, Inc.

Nagisa develops cell culture products and diagnostic tools for research and therapeutic applications.

About

Founded in 2010 and based in Tokyo, Japan, Nagisa develops cell culture products and diagnostic tools for research and therapeutic use. In December 2023, it raised JPY 400 million in Series A funding from Mint, Money Forward Venture Partners, and W Fund. The funding is intended for product development, hiring, and strengthening its management base.

3Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in